Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-15

Clinical Trial Update: A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the long-term efficacy of nebivolol after withdrawal of therapy in hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-09-15